Rafael Bejar - Net Worth and Insider Trading
Rafael Bejar Net Worth
The estimated net worth of Rafael Bejar is at least $255 dollars as of 2024-11-06. Rafael Bejar is the Sr. VP, Chief Medical Officer of Aptose Biosciences Inc and owns about 667 shares of Aptose Biosciences Inc (APTO) stock worth over $255. Details can be seen in Rafael Bejar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rafael Bejar has not made any transactions after 2021-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rafael Bejar
Rafael Bejar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rafael Bejar owns 1 companies in total, including Aptose Biosciences Inc (APTO) .
Click here to see the complete history of Rafael Bejar’s form 4 insider trades.
Insider Ownership Summary of Rafael Bejar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APTO | Aptose Biosciences Inc | 2021-11-19 | Chief Medical Officer |
Rafael Bejar Latest Holdings Summary
Rafael Bejar currently owns a total of 1 stock. Rafael Bejar owns 667 shares of Aptose Biosciences Inc (APTO) as of November 19, 2021, with a value of $255.
Latest Holdings of Rafael Bejar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APTO | Aptose Biosciences Inc | 2021-11-19 | 667 | 0.38 | 255 |
Holding Weightings of Rafael Bejar
Rafael Bejar Form 4 Trading Tracker
According to the SEC Form 4 filings, Rafael Bejar has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 667 shares on November 19, 2021, which cost Rafael Bejar around $25,600.
Insider Trading History of Rafael Bejar
- 1
Rafael Bejar Trading Performance
GuruFocus tracks the stock performance after each of Rafael Bejar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rafael Bejar is -53.39%. GuruFocus also compares Rafael Bejar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rafael Bejar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rafael Bejar's insider trading performs compared to the benchmark.
Performance of Rafael Bejar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40.24 | | | | | |
| Relative Return to S&P 500(%) | -38.59 | | | | | |
Rafael Bejar Ownership Network
Ownership Network List of Rafael Bejar
Ownership Network Relation of Rafael Bejar
Rafael Bejar Owned Company Details
What does Aptose Biosciences Inc do?
Who are the key executives at Aptose Biosciences Inc?
Rafael Bejar is the Chief Medical Officer of Aptose Biosciences Inc. Other key executives at Aptose Biosciences Inc include director & Chair & President & CEO William G. Rice , SR VP & Chief Fin. Officer Fletcher Payne , and Chief Commercial Officer Philippe Ledru .
Aptose Biosciences Inc (APTO) Insider Trades Summary
Over the past 18 months, Rafael Bejar made no insider transaction in Aptose Biosciences Inc (APTO). Other recent insider transactions involving Aptose Biosciences Inc (APTO) include a net purchase of 17,000 shares made by Bernd R. Seizinger ,
In summary, during the past 3 months, insiders sold 0 shares of Aptose Biosciences Inc (APTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptose Biosciences Inc (APTO) were sold and 17,000 shares were bought by its insiders, resulting in a net purchase of 17,000 shares.
Aptose Biosciences Inc (APTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptose Biosciences Inc Insider Transactions
Rafael Bejar Mailing Address
Above is the net worth, insider trading, and ownership report for Rafael Bejar. You might contact Rafael Bejar via mailing address: C/o Aptose Biosciences Inc., 251 Consumers Road, Suite 1105, Toronto A6 M2j 4r3.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
